Payers
What the government reopening means for healthcare
From insurance subsidies to telehealth, the new funding law has major implications for the industry.
Maia is a Minnesota-based senior reporter and founding reporter of Healthcare Brew, where she covers the pharmacy industry, women’s health, digital health, and how venture capital is shaping healthcare. She previously worked as a fellow covering the aerospace industry at Insider, as well as a healthcare reporter for Becker's Hospital Review. She has won an award from the Society of Professional Journalists for her work.
Retail Pharmacies
What Express Scripts’s move to eliminate rebates means for the industry
The move will hit insurers, drugmakers, and patients differently.
Retail Pharmacies
How alternative PBMs are shaking up the industry
As major PBMs weather trials and investigations, alternatives promise an easier way.
Pharma
What new advertising rules may mean for pharma companies
The Trump administration’s crackdown on direct-to-consumer pharma ads could make TV advertising “very expensive and very difficult,” one expert said.
Pharma
Healthcare execs on the state of psychedelic medicine
While there’s still a long way to go, the industry is starting to embrace psychedelics.
Direct Care
How MiSalud Health tailors care to the Hispanic population
The telehealth company offers a range of primary care and behavioral health services.
Tech
Doctors using AI for clinical decision-making viewed negatively by peers, study finds
But clinicians still view AI positively overall.
Retail Pharmacies
What Omnicare’s bankruptcy could mean for CVS
The subsidiary filed for Chapter 11 protection after being ordered to pay nearly $1 billion in penalties for alleged overbilling.
Tech
HHS says it’s upping enforcement of information blocking rules
And violators could face up to $1 million in fines.
Retail Pharmacies
Why employers are moving away from the Big 3 PBMs
Though the Big 3 control the majority of the market, alternative PBMs are gaining more traction.